-+ 0.00%
-+ 0.00%
-+ 0.00%
Devyser launches next-generation chimerism analysis assay for post-transplant monitoring
Share
Listen to the news
Devyser launches next-generation chimerism analysis assay for post-transplant monitoring
  • Devyser launched One Lambda Devyser Chimerism Plus, a next-generation chimerism analysis assay for post-allogeneic HSCT monitoring.
  • Product design targets fewer workflow errors, higher lab efficiency, improved ease of use versus the existing chimerism monitoring assay.
  • Launch expands the Thermo Fisher collaboration, using Thermo Fisher’s commercial network to broaden distribution and support growth ambitions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Devyser Diagnostics AB published the original content used to generate this news brief on July 16, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending